| [1] |
李海波, 符洪源, 陆桐宇等. 肝移植领域2017年度重要进展盘点[J]. 器官移植, 2018, 9(1):41-50,82.
|
| [2] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
|
| [3] |
胡倩, 姚和瑞. 长链非编码RNA与肿瘤研究现状[J]. 中华肿瘤防治杂志, 2014, 21(21):1746-1750.
|
| [4] |
王明娟, 周晓慧, 江小华. 长链非编码RNA与肿瘤发生发展关系的研究进展[J]. 临床和实验医学杂志, 2015, 14(5):431-433.
|
| [5] |
Washietl S, Kellis M, Garber M. Evolutionary dynamics and tissue specificity of human long noncoding RNAs in six mammals[J]. Genome Res, 2014, 24(4):616-628.
|
| [6] |
Tamura M, Hendrix D K, Klosterman P S, et al. SCOR: Structural Classification of RNA, version 2.0[J]. Nucleic Acids Res, 2004, 32 (Database issue): D182-D184.
|
| [7] |
Rinn JL, Chang HY. Genome regulation by long noncoding RNAs[J]. Annu Rev Biochem, 2012, 81(1):145-166.
|
| [8] |
黎梨, 邓凤莲, 黄赞松, 等. 长链非编码RNA-H19调控人肝癌HepG2细胞增殖与凋亡[J]. 右江民族医学院学报, 2019, 41(1):15-19.
|
| [9] |
Li L, Han T, Liu K, et al. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23(12):5392-5401.
|
| [10] |
Chen H, Pei H, Hu W, et al. Long non-coding RNA CRYBG3 regulates glycolysis of lung cancer cells by interacting with lactate dehydrogenase A[J]. J Cancer, 2018, 9(14):2580-2588.
|
| [11] |
Li X, Zhao Q, Qi J, et al. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARgamma pathway in hepatocellular carcinoma[J]. Int J Oncol, 2018, 53(2):551-566.
|
| [12] |
陈思玉, 陈建安, 刘丽文, 等. 长链非编码RNA HCG18对肝癌细胞生物学活性的影响[J]. 河南医学研究, 2019, 28(1):7-10.
|
| [13] |
Xue JY, Huang C, Wang W, et al. HOXA11-AS: a novel regulator in human cancer proliferation and metastasis[J]. Onco Targets Ther, 2018, 11(7):4387-4393.
|
| [14] |
Liu RT, Cao JL, Yan CQ, et al. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721[J]. Biosci Rep, 2017, 37(2): R20160532.
|
| [15] |
Jiang R, Tang J, Chen Y, et al. The long noncoding RNA lnc- EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion[J]. Nat Commun, 2017, 8(1):15129.
|
| [16] |
Yang L, Peng F, Qin J, et al. Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1[J]. Oncol Rep, 2017, 38(4):2148-2154.
|
| [17] |
梁帆, 文荃, 唐宗伟, 等. 长链非编码RNA EHHADH-AS1在HBV~+肝细胞癌中的作用及其机制[J]. 第三军医大学学报, 2018, 40(21):1922-1931.
|
| [18] |
邱建国, 史政荣, 李明. 长链非编码RNA GAS5在肝细胞性肝癌中的表达及其临床意义[J]. 中国普外基础与临床杂志, 2019, 26(3):301-306.
|
| [19] |
Fang P, Xiang L, Chen W, et al. LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3[J]. Innate Immun, 2019, 25(2):99-109.
|
| [20] |
李岩, 杨大业, 张德巍. 长链非编码RNA MEG3对肝癌细胞增殖及自噬能力的影响[J]. 现代肿瘤医学, 2019, 27(3):382-385.
|
| [21] |
Fu Y, Xu Y, Chen S, et al. MiR151a-3p promotes postmenopausal osteoporosis by targeting SOCS5 and activating JAK2/STAT3 signaling[J]. Rejuvenation Res, 2019. [Epub ahead of print]
|
| [22] |
Teoh PJ, Chung TH, Chng P, et al. IL6R-STAT3-ADAR1(P150) interplay promotes oncogenicity in 1q21(amp) multiple myeloma[J]. Haematologica, 2019. [Epub ahead of print]
|
| [23] |
Wu DM, Zheng ZH, Zhang YB, et al. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells[J]. J Exp Clin Cancer Res, 2019, 38(1):237.
|
| [24] |
Lin Q, Zheng H, Xu J, et al. LncRNA SNHG16 aggravates tumorigenesis and development of hepatocellular carcinoma by sponging miR-4500 and targeting STAT3[J]. J Cell Biochem, 2019, 120(7):11604-11615.
|
| [25] |
Song W, Gu Y, Lu S, et al. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex[J]. Cell Prolif, 2019, 52(4):e12621.
|
| [26] |
Wu G, Wang Y, Lu X, et al. Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma[J]. BMC Cancer, 2015, 15:182.
|
| [27] |
Nie J, Liu L, Zheng W, et al. microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2[J]. Carcinogenesis, 2012, 33(1):220-225.
|
| [28] |
Wang Y, Hu Y, Wu G, et al. Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372[J]. Oncotarget, 2017, 8(21):34429-34441.
|
| [29] |
White NM, Zhao SG, Zhang J, et al. Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer[J]. Eur Urol, 2017,71(2):257-266.
|
| [30] |
Hu JJ, Song W, Zhang SD, et al. HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling[J]. Sci Rep, 2016, 6(1):23521.
|
| [31] |
Tang Q, Wang Q, Zhang Q, et al. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para- tumor and normal tissues[J]. BMC Cancer, 2017, 17(1):862.
|
| [32] |
Gao J, Yin X, Yu X, et al. Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA-122-5p to regulate ADAM10 expression[J]. J Cell Biochem, 2019,120(10):16393-16407.
|
| [33] |
Ruan L, Huang L, Zhao L, et al. The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients[J]. Gastroenterol Res Pract, 2018, 2018(1):9187316.
|
| [34] |
Zhong JH, Xiang X, Wang YY, et al. The lncRNA SNHG16 affects prognosis in hepatocellular carcinoma by regulating p62 expression[J]. J Cell Physiol, 2020, 235(2):1090-1102.
|
| [35] |
Cao S, Lin L, Xia X, et al. lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer[J]. Mol Ther Nucleic Acids, 2019, 17:455-464.
|
| [36] |
Liu C, Feng Z, Chen T, et al. Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway[J]. Cell Cycle, 2019, 18(2):167-203.
|
| [37] |
Zhang X, Gao D, Fang K, et al. Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway[J]. Cancer Lett, 2019, 444:105-115.
|
| [38] |
Chen X, Zhang N. Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis[J]. Cell Biol Int, 2019, 43(1):44-55.
|
| [39] |
Mehlmann LM, Uliasz TF, Lowther KM. SNAP23 is required for constitutive and regulated exocytosis in mouse oocytes[J]. Biol Reprod, 2019, 101(2):338-346.
|
| [40] |
Cheng D, Deng J, Zhang B, et al. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation[J]. EBioMedicine, 2018, 36:159-170.
|
| [41] |
Williams CM, Li Y, Brown E, et al. Platelet-specific deletion of SNAP23 ablates granule secretion, substantially inhibiting arterial and venous thrombosis in mice[J]. Blood Adv, 2018, 2(24):3627-3636.
|
| [42] |
Yang L, Peng X, Li Y, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma[J]. Mol Cancer, 2019, 18(1):78.
|
| [43] |
Ding H, Liu J, Zou R, et al. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation[J]. J Exp Clin Cancer Res, 2019, 38(1):189.
|
| [44] |
Zhou W, He Y, Rehman AU, et al. Author Correction: Loss of function of NCOR1 and NCOR2 impairs memory through a novel GABAergic hypothalamus-CA3 projection[J]. Nat Neurosci, 2019, 22(9):1533.
|
| [45] |
Chen ZB, Cao WL, Su K, et al. MIR22HG inhibits cell growth, migration and invasion through regulating the miR-24-3p/p27kip1 axis in thyroid papillary carcinomas[J]. Eur Rev Med Pharmacol Sci, 2019, 23(13):5851-5862.
|
| [46] |
Wu Y, Zhou Y, Huan L, et al. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells[J]. Cancer Sci, 2019, 110(3):973-984.
|
| [47] |
Sui C, Dong Z, Yang C, et al. LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma[J]. J Cell Mol Med, 2019, 23(9):6024-6033.
|
| [48] |
Li M, Guan H, Liu Y, et al. LncRNA ZEB1-AS1 reduces liver cancer cell proliferation by targeting miR-365a-3p[J]. Exp Ther Med, 2019, 17(5):3539-3547.
|
| [49] |
Wang H, Huo X, Yang XR, et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4[J]. Mol Cancer, 2017, 16(1):136.
|
| [50] |
Qian W, Cai X, Qian Q, et al. lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial-mesenchymal transition by competitively binding miR-141-3p[J]. Cell Death Dis, 2019, 10(2):129.
|
| [51] |
Li M, Yang Y, Kuang Y, et al. miR-365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl-2[J]. Exp Ther Med, 2017, 13(5):2279-2285.
|
| [52] |
Su W, Xu M, Chen X, et al. Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer[J]. Mol Cancer, 2017, 16(1):142.
|
| [53] |
Gong J, Wang J, Liu T, et al. lncRNA FEZF1AS1 contributes to cell proliferation, migration and invasion by sponging miR4443 in hepatocellular carcinoma[J]. Mol Med Rep, 2018, 18(6):5614-5620.
|
| [54] |
Chen Z, Xu D, Zhang T. Inhibition of proliferation and invasion of hepatocellular carcinoma cells by lncRNA-ASLNC02525 silencing and the mechanism[J]. Int J Oncol, 2017, 51(3):851-858.
|
| [55] |
Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis[J]. Cell, 2004, 117(7):927-939.
|
| [56] |
Bao L, Zhang X, Shi YZ, et al. Understanding the Relative Flexibility of RNA and DNA Duplexes: Stretching and Twist-Stretch Coupling[J]. Biophys J, 2017, 112(6):1094-1104.
|